Avantor® and NIBRT Collaborate to Advance Bioprocessing by Addressing Downstream Bottlenecks in Monoclonal Antibodies (mAbs) Production
Avantor, Inc. and NIBRT are teaming up to address downstream bottlenecks in buffer preparation when producing monoclonal antibodies (mAbs).
As part of the joint effort, Avantor is providing in-line dilution systems for hands-on experience at NIBRT’s prestigious training and research facility dedicated to supporting the global bioprocessing industry. Avantor’s technology adds to NIBRT’s full complement of bioprocessing capabilities.
You can read the full press release here